Clinical Trial Update: Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric Cancer

View source ↗

Summary

This document reports a completed non-interventional study evaluating Xeloda (capecitabine) in patients with gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Status: COMPLETED